伊朗消除型肝炎病毒:全面战略的蓝图
SeyedehFatemeh Mousavi1, Maryam Alavi2, Alireza Delavari1
1Digestive Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Journal of viral hepatitis
|June 4, 2024
概括
伊朗的目标是到2030年消除型肝炎病毒 (HCV) 通过针对高风险人群提供可访问的测试和治疗. 一个全面的战略包括预防,教育和政策改革,以消除HCV.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 型肝炎病毒 (HCV) 仍然是一个重要的全球卫生问题,伊朗面临着类似的挑战.
- 世界卫生组织 (WHO) 设定了到2030年消除HCV的目标.
- 需要有效的战略来解决伊朗持续存在的HCV负担.
研究的目的:
- 概述一项全面的战略,以消除伊朗的HCV.
- 确定用于HCV控制的关键干预措施和目标人群.
- 为实现世卫组织2030年HCV消除目标提出综合方法.
主要方法:
- 专注于高风险群体,包括注射毒品的人和囚犯.
- 在减少伤害设施和监狱中实施点诊疗检测和治疗.
- 使用具有成本效益的通用直接作用抗病毒药物 (DAA).
- 为医疗保健提供者制定教育计划和开展公众宣传活动.
- 解决社会耻辱,确保治疗负担能力.
- 建立强大的监控和数据管理系统.
- 定期进行政策审查.
主要成果:
- 拟议的战略整合了预防,查和弱势群体的治疗.
- 使用通用DAA为广泛治疗提供了具有成本效益的解决方案.
- 教育和意识倡议对于行为改变和早期检测至关重要.
- 解决污名和负担能力等社会经济因素对于计划的成功至关重要.
- 要实现HCV消除目标,需要采用多方面的方法.
结论:
- 对于伊朗来说,制定一项全面,综合的战略至关重要,以便在2030年之前实现HCV消除.
- 针对高风险群体和利用可获得的,具有成本效益的治疗方法是关键组成部分.
- 这种方法可以作为其他面临类似HCV挑战的国家的典范.
相关概念视频
Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Drug Elimination: Non-Renal Routes
2.3K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.3K
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Enhanced Elimination of Poison
498
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
498


